OLD National Bancorp IN Raises Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

OLD National Bancorp IN lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,974 shares of the company’s stock after purchasing an additional 168 shares during the period. OLD National Bancorp IN’s holdings in Prestige Consumer Healthcare were worth $287,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Ariel Investments LLC grew its stake in Prestige Consumer Healthcare by 10.7% in the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after acquiring an additional 274,212 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Prestige Consumer Healthcare by 26.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock worth $90,891,000 after purchasing an additional 272,773 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Prestige Consumer Healthcare by 9.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after purchasing an additional 171,357 shares during the period. F M Investments LLC bought a new stake in Prestige Consumer Healthcare during the 2nd quarter valued at $11,162,000. Finally, Norden Group LLC lifted its holdings in shares of Prestige Consumer Healthcare by 1,593.7% in the 1st quarter. Norden Group LLC now owns 118,968 shares of the company’s stock worth $8,632,000 after buying an additional 111,944 shares during the period. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $72.18 on Thursday. The stock’s 50-day moving average is $71.65 and its 200 day moving average is $69.33. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The company has a market cap of $3.59 billion, a P/E ratio of 17.31, a PEG ratio of 2.05 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $267.10 million for the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company’s revenue was down 4.4% compared to the same quarter last year. During the same period last year, the business earned $1.06 EPS. Research analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PBH has been the subject of several recent research reports. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.